Results 241 to 250 of about 1,407,116 (362)

Understanding Mechanisms of Whole Brain and Regional Grey Matter Atrophy in Children With MOGAD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the mechanisms driving whole brain and regional grey matter (GM) volume changes along with their clinical correlates in paediatric myelin oligodendrocyte glycoprotein antibody (MOG‐Ab)–associated disease (MOGAD). Methods One‐hundred‐nine paediatric MOGAD patients from two UK centres underwent MRI at attack nadir and ...
Ermelinda De Meo   +14 more
wiley   +1 more source

2200 Preparing diagnostic 3D images for image registration with planning CT images

open access: bronze, 1997
Gregg Tracton   +6 more
openalex   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li   +10 more
wiley   +1 more source

The role of deep learning in diagnostic imaging of spondyloarthropathies: a systematic review. [PDF]

open access: yesEur Radiol
Omar M   +6 more
europepmc   +1 more source

A CLINICAL APPLICATION FOR THREE-DIMENSIONAL DIAGNOSTIC IMAGING OF THE TRACHEOBRONCHUS AND LARGE BLOOD VESSELS BY USING A SPIRAL VOLUMETRIC CT OF THE PULMONARY HILAM AND MEDIASTINUM

open access: bronze, 1996
R Amemiya   +9 more
openalex   +1 more source

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji   +9 more
wiley   +1 more source

Myocardial Infarction with Obstructive, Non-Obstructive, and Mimicking Conditions: Clinical Phenotypes, Diagnostic Imaging, Management, and Prognosis. [PDF]

open access: yesJ Clin Med
Samaras A   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy